ChromoGenics AB (CHRO.ST)

SEK 9.8

(0.2%)

Operating Expenses Summary of ChromoGenics AB

ChromoGenics AB's latest annual operating expenses in 2023 was 55.82 Million SEK , down -8.23% from previous year.
ChromoGenics AB's latest quarterly operating expenses in 2024 Q2 was -29.6 Million SEK , down -323.48% from previous quarter.
ChromoGenics AB reported a annual operating expenses of 60.83 Million SEK in annual operating expenses 2022, down -12.61% from previous year.
ChromoGenics AB reported a annual operating expenses of 69.61 Million SEK in annual operating expenses 2021, up 21.08% from previous year.
ChromoGenics AB reported a quarterly operating expenses of 13.24 Million SEK for 2024 Q1, down -16.4% from previous quarter.
ChromoGenics AB reported a quarterly operating expenses of 11.29 Million SEK for 2023 Q3, down -21.61% from previous quarter.

Annual Operating Expenses Chart of ChromoGenics AB (2023 - 2013)

Historical Annual Operating Expenses of ChromoGenics AB (2023 - 2013)

Year	Operating Expenses	Operating Expenses Growth
2023	55.82 Million SEK	-8.23%
2022	60.83 Million SEK	-12.61%
2021	69.61 Million SEK	21.08%
2020	57.49 Million SEK	-21.41%
2019	73.15 Million SEK	45.63%
2018	50.23 Million SEK	45.29%
2017	34.57 Million SEK	-8.53%
2016	37.8 Million SEK	-13.14%
2015	43.52 Million SEK	36.09%
2014	31.98 Million SEK	-15.75%
2013	37.95 Million SEK	0.0%

Year	Operating Expenses	Operating Expenses Growth
2024 Q2	-29.6 Million SEK	-323.48%
2024 Q1	13.24 Million SEK	-16.4%
2023 Q3	11.29 Million SEK	-21.61%
2023 FY	55.82 Million SEK	-8.23%
2023 Q2	14.41 Million SEK	1.02%
2023 Q1	14.26 Million SEK	-8.19%
2023 Q4	15.84 Million SEK	40.25%
2022 Q3	14.22 Million SEK	-4.56%
2022 FY	60.83 Million SEK	-12.61%
2022 Q1	16.15 Million SEK	-11.72%
2022 Q2	14.9 Million SEK	-7.75%
2022 Q4	15.53 Million SEK	9.22%
2021 FY	69.61 Million SEK	21.08%
2021 Q3	11.38 Million SEK	-60.89%
2021 Q2	29.11 Million SEK	169.59%
2021 Q4	18.3 Million SEK	60.73%
2021 Q1	10.8 Million SEK	-11.56%
2020 FY	57.49 Million SEK	-21.41%
2020 Q4	12.21 Million SEK	-6.07%
2020 Q3	13 Million SEK	-7.38%
2020 Q2	14.03 Million SEK	-23.03%
2020 Q1	18.23 Million SEK	-38.32%
2019 Q3	14.42 Million SEK	-10.91%
2019 Q1	12.96 Million SEK	-23.49%
2019 FY	73.15 Million SEK	45.63%
2019 Q4	29.57 Million SEK	104.97%
2019 Q2	16.19 Million SEK	24.91%
2018 Q1	14.02 Million SEK	16.39%
2018 Q4	16.94 Million SEK	105.92%
2018 FY	50.23 Million SEK	45.29%
2018 Q3	8.22 Million SEK	-25.46%
2018 Q2	11.04 Million SEK	-21.27%
2017 FY	34.57 Million SEK	-8.53%
2017 Q4	12.04 Million SEK	41.21%
2017 Q3	8.53 Million SEK	13.65%
2017 Q2	7.5 Million SEK	15.67%
2017 Q1	6.49 Million SEK	-27.52%
2016 Q1	9.57 Million SEK	-26.26%
2016 FY	37.8 Million SEK	-13.14%
2016 Q4	8.95 Million SEK	1.12%
2016 Q3	8.85 Million SEK	-14.84%
2016 Q2	10.39 Million SEK	8.57%
2015 Q3	7.52 Million SEK	0.0%
2015 Q4	12.98 Million SEK	72.58%
2015 FY	43.52 Million SEK	36.09%
2014 FY	31.98 Million SEK	-15.75%
2013 FY	37.95 Million SEK	0.0%

Peer Operating Expenses Comparison of ChromoGenics AB

Name	Operating Expenses	Operating Expenses Difference
Balco Group AB	161.56 Million SEK	65.449%
Byggmax Group AB (publ)	26 Million SEK	-114.704%
Ecoclime Group AB (publ)	166.99 Million SEK	66.572%
FM Mattsson Mora Group AB (publ)	509.3 Million SEK	89.039%
Inwido AB (publ)	1.31 Billion SEK	95.77%
Lindab International AB (publ)	2.05 Billion SEK	97.284%
NIBE Industrier AB (publ)	10.65 Billion SEK	99.476%
Nordic Waterproofing Holding AB (publ)	820.9 Million SEK	93.2%
Polyplank AB (publ)	26.35 Million SEK	-111.78%
Svedbergs i Dalstorp AB (publ)	567.6 Million SEK	90.165%
Systemair AB (publ)	3.25 Billion SEK	98.283%